Screener
10x Genomics, Inc. TXG Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s accounts receivable?
- 10x Genomics, Inc. (TXG) reported accounts receivable of $47.55M in Q2 2026.
- How has 10x Genomics, Inc.'s accounts receivable changed year-over-year?
- 10x Genomics, Inc.'s accounts receivable decreased by 4.9% year-over-year, from $49.98M to $47.55M.
- What is the long-term trend for 10x Genomics, Inc.'s accounts receivable?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s accounts receivable has grown at a -1.7% compound annual growth rate (CAGR), from $51.21M to $47.01M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about 10x Genomics, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude